Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burger

Showing results (751-760 of 1,123) with videos related to

Pageof 113
Sort By:
Pediatrics|August 8, 2002
Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavirAnnemarie M C van Rossum, Jeanne P Dieleman, Pieter L A Fraaij, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 2008
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individualsLaura Dickinson, Marta Boffito, David J Back, et al.
Antiviral Therapy|October 11, 2017
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescentsWatsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Naruporn Kasipong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2008
Therapeutic drug monitoring of nevirapine in resource-limited settingsRafaëlla F A L'homme, Eva P Muro, Jacqueline A H Droste, et al.
Der Urologe. Ausg. A|June 9, 2017
[What is the perception of the 10-point plan of the German Federal Ministry of Health against multidrug-resistant pathogens and measures of antibiotic stewardship? : An interdisciplinary analysis among German clinicians and development of a decision tool for urologists]M May, M W Vetterlein, F M Wagenlehner, et al.
Therapeutic Drug Monitoring|January 29, 2015
Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass SpectrometryCorrien P W G M Verweij-van Wissen, Marga J A de Graaff-Teulen, Clara T M M de Kanter, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2015
Altered Micafungin Pharmacokinetics in Intensive Care Unit PatientsVincent J Lempers, Jeroen A Schouten, Nicole G Hunfeld, et al.
Antiviral Therapy|August 20, 2003
Pharmacokinetics of nelfinavir in children: influencing factors and dose implicationsAlina S Bergshoeff, Pieter L A Fraaij, Annemarie M C van Rossum, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteersJ A H Droste, C P W G M Verweij-van Wissen, B P Kearney, et al.
Antiviral Therapy|August 3, 2007
Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and belowGwenda Verweel, David M Burger, Nancy L Sheehan, et al.
Pageof 113

Showing results (751-760 of 1,123) with videos related to

Sort By:
Pageof 113
Pediatrics|August 8, 2002
Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavirAnnemarie M C van Rossum, Jeanne P Dieleman, Pieter L A Fraaij, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 2008
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individualsLaura Dickinson, Marta Boffito, David J Back, et al.
Antiviral Therapy|October 11, 2017
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescentsWatsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Naruporn Kasipong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2008
Therapeutic drug monitoring of nevirapine in resource-limited settingsRafaëlla F A L'homme, Eva P Muro, Jacqueline A H Droste, et al.
Der Urologe. Ausg. A|June 9, 2017
[What is the perception of the 10-point plan of the German Federal Ministry of Health against multidrug-resistant pathogens and measures of antibiotic stewardship? : An interdisciplinary analysis among German clinicians and development of a decision tool for urologists]M May, M W Vetterlein, F M Wagenlehner, et al.
Therapeutic Drug Monitoring|January 29, 2015
Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass SpectrometryCorrien P W G M Verweij-van Wissen, Marga J A de Graaff-Teulen, Clara T M M de Kanter, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2015
Altered Micafungin Pharmacokinetics in Intensive Care Unit PatientsVincent J Lempers, Jeroen A Schouten, Nicole G Hunfeld, et al.
Antiviral Therapy|August 20, 2003
Pharmacokinetics of nelfinavir in children: influencing factors and dose implicationsAlina S Bergshoeff, Pieter L A Fraaij, Annemarie M C van Rossum, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteersJ A H Droste, C P W G M Verweij-van Wissen, B P Kearney, et al.
Antiviral Therapy|August 3, 2007
Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and belowGwenda Verweel, David M Burger, Nancy L Sheehan, et al.
Pageof 113